New weekly shot helps shed pounds in major chinese obesity trial
NCT ID NCT04904913
First seen Nov 17, 2025 · Last updated May 13, 2026 · Updated 31 times
Summary
This study tested a new drug called IBI362 in 328 overweight or obese Chinese adults. Participants received weekly injections of different doses of IBI362 or a placebo for 24 weeks, while also following diet and exercise plans. The main goal was to see how much weight people lost, and the results showed significant reductions in body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University people's hospital
Beijing, Beijing Municipality, 100044, China
Conditions
Explore the condition pages connected to this study.